03-26-2026Price:

The Frontier

Your signal. Your price.

SCIENCE

Psychedelics emerge as quantified anti-aging therapy

Thursday, March 26, 2026 · from 2 podcasts
All-In with Chamath, Jaso…The Peter Attia Drive
  • Bryan Johnson's data-driven experiments show high-dose psilocybin can rapidly reset metabolic aging markers like blood glucose and inflammation.
  • The anti-aging mechanism may be neural: dismantling the brain's rigid 'default mode network' to restore youthful neuroplasticity and stress responses.
  • Traditional longevity experts like Peter Attia remain focused on managing metabolic and cardiovascular disease with established tools, viewing cancer and dementia as greater unknowns.

Psychedelics are being rebranded from mental health tools to quantified longevity drugs.

On the All-In podcast, Bryan Johnson detailed a controlled experiment with three high 25-milligram doses of psilocybin. The goal was physical rejuvenation, not psychological healing. The biomarkers told a stark story: Johnson's blood glucose, previously in the elite 99.5th percentile for low levels, dropped to the even more exceptional 99.9th percentile. He reported similar dramatic reductions in inflammation and shifts in gut microbiome composition.

Bryan Johnson, All-In with Chamath, Jason, Sacks & Friedberg:

- It had this metabolic reset in the brain where my blood glucose before this was in the top 99.5 percentile of all the population.

- After it went to the top 99.9 percentile. Like to move my blood glucose from that level is very, very hard.

The proposed mechanism is neural. Johnson argues psychedelics like psilocybin and the even more potent 5-MeO-DMT forcibly quiet the brain's default mode network - the circuit responsible for self-referential thought and ego. Scrambling this hardened adult pattern, he claims, resets the brain to a more neuroplastic, childlike state. He cites waking up laughing from dreams and resolving conflict without adult defensiveness as evidence of a lasting cognitive shift.

This frames ego death not as a spiritual event, but as a measurable intervention against the neural rigidity of aging.

That perspective contrasts with the established longevity playbook. On The Peter Attia Drive, physician Peter Attia ranks metabolic and cardiovascular disease as the least concerning of the 'four horsemen' of chronic illness, precisely because they are well-understood and manageable with existing tools like diet and medication.

Peter Attia, The Peter Attia Drive:

- I worry the least about metabolic disease and cardiovascular and cerebrovascular disease because one we have a pretty good handle on the drivers of those diseases.

- In fact, we have an exceptional handle on the driver of those diseases.

For Attia, the greater threats are cancer, due to its random element, and neurodegenerative diseases like dementia, where preventive tools are still nascent. His age-based strategy emphasizes building capacity in youth, locking in prevention in midlife, and focusing on maintenance later.

The divergence is clear. Johnson is experimenting at the frontier, using psychedelics to aggressively reset aging pathways Attia considers already solved. One view seeks to master the known; the other is betting on a new, systemic reset.

LongevityHealthBiology

Source Intelligence

What each podcast actually said

All-In with Chamath, Jason, Sacks & Friedberg
All-In with Chamath, Jason, Sacks & Friedberg

Bryan Johnson: I Just Took the Most Powerful Dose of DMT in the World... Here's What It Was Like • Mar 26

  • Bryan Johnson argues high-dose psychedelics like psilocybin are a longevity therapy, not just mental health medicine, because they reset metabolic and neural aging pathways.
  • In a quantified experiment, Johnson found a high 25-milligram dose of psilocybin lowered his blood glucose from the 99.5th to the 99.9th percentile, a shift he says is more dramatic than what metformin achieves.
  • Johnson's data showed psilocybin altered his gut microbiome and reduced systemic inflammation, targeting a core biological driver of aging.
  • The key longevity benefit Johnson observes is a durable, childlike neuroplastic state post-experience, evidenced by a quieted internal monologue and simple, non-defensive conflict resolution.
  • Johnson's quantified approach aims to reframe the psychedelic experience from spiritual anecdote to a measurable biomarker reset of the aging clock.

Also from this episode:

Brain (2)
  • Johnson describes the brain's default mode network as an engine that constructs the ego and hardens with age, narrowing our experience of reality through patterns of rumination.
  • Psychedelics like psilocybin work by scrambling the neural traffic patterns of the default mode network, facilitating a systemic neurological reset.
Psychology (1)
  • Johnson characterizes the 5-MeO-DMT experience as a 10-second blast into a non-visual space of raw consciousness, requiring total surrender of ego to unlock unimaginable bliss.
HealthLongevityPsychology
The Peter Attia Drive
The Peter Attia Drive

#385 - AMA #82: Applying the tools of longevity in the real world: disease prevention, DEXA scans, artificial sweeteners, injury recovery, stability training, habit formation, protein intake and mTOR activation, and more • Mar 23

  • Peter Attia ranks metabolic and cardiovascular diseases as the least worrisome among major chronic killers, arguing we have exceptional understanding of their drivers and powerful existing tools for management.
  • Attia places cancer in a higher tier of concern because approximately 50% of cases occur in individuals with no observable risk factors like smoking or metabolic dysfunction.
  • Attia cites Bert Vogelstein's 'bad luck' hypothesis, framing cancer risk as a cellular game of Russian roulette where random DNA mutations can evade repair and immune surveillance, making screening protocols paramount.
  • Attia views neurodegenerative diseases like dementia as the most concerning due to still-evolving prevention tools, placing them in a distinct category of risk.
  • Attia advises a lifespan-specific strategy: in your 20s, push physical limits and explore capacity because the body's recovery ability is high.
  • Attia argues the 40s should focus on deliberate prevention, locking in metabolic health and consistent exercise habits before significant disease burden accumulates.
  • Attia frames the 60s and beyond as a phase for maintenance or late-stage transformation, stressing it's not too late for major fitness and prevention gains for those entering older age in poor health.
HealthLongevityBiology